首页 > 最新文献

Enfermedades infecciosas y microbiologia clinica (English ed.)最新文献

英文 中文
Human intestinal spirochetosis: an entity associated with sexual transmitted infections 人类肠道螺旋体病:与性传播感染有关的一个实体
Pub Date : 2024-05-01 DOI: 10.1016/j.eimce.2023.05.003
Alejandro De Gea-Grela , Alfredo Maldonado-Barrueco , Clara Cabañuz , Mariana Díaz-Almiron , Alicia Rico , Guillermo Ruíz-Carrascoso , Maria Elena Palacios , Eduardo Martín-Arranz , Raquel Escudero-Nieto , José I Bernardino

Introduction

Human intestinal spirochetosis (HIE) is a poorly studied clinical entity with variable clinical manifestations. However, in recent years it has gained special relevance because an increasing number of cases have been described in people living with HIV (PWH) and in patients with a history of sexually transmitted infections (STI) or immunosuppression.

Methods

Retrospective review of all HIE cases identified in a tertiary level hospital (Hospital Universitario la Paz, Madrid) between 2014 and 2021.

Results

36 Cases of HIE were identified. Most cases corresponded to males (94%) with a median age of 45 years. 10 patients (29.4%) were PWH and 20 (56%) were men who had sex with men. Although the clinical manifestations were very heterogeneous, the most frequent was chronic diarrhea (47%), and up to 25% of the subjects had clinical proctitis. 39% percent of patients had been diagnosed with an STI in the previous two years, this characteristic being more frequent in PWH (90% vs. 28%; p < 0.01) than in patients without HIV infection. The STI most frequently associated with a diagnosis of HIE was syphilis (31%).

Conclusion

HIE is frequently diagnosed with other STIs and affects mostly men who have sex with men, which supports that this entity could be considered as a new STI.

导言人类肠道螺旋体病(HIE)是一种临床研究较少的疾病,临床表现多变。方法回顾性分析一家三级甲等医院(马德里帕斯大学医院)在2014年至2021年间发现的所有HIE病例。大多数病例为男性(94%),中位年龄为 45 岁。10名患者(29.4%)为重症肝炎患者,20名患者(56%)为男男性行为者。虽然临床表现各不相同,但最常见的是慢性腹泻(47%),多达 25% 的受试者患有临床直肠炎。39%的患者在过去两年中被诊断出患有性传播疾病,与未感染艾滋病毒的患者相比,PWH 患者的这一特征更为常见(90% 对 28%;p <0.01)。结论HIE经常与其他性传播感染同时被诊断出来,并且主要影响男男性行为者,这证明该疾病可被视为一种新的性传播感染。
{"title":"Human intestinal spirochetosis: an entity associated with sexual transmitted infections","authors":"Alejandro De Gea-Grela ,&nbsp;Alfredo Maldonado-Barrueco ,&nbsp;Clara Cabañuz ,&nbsp;Mariana Díaz-Almiron ,&nbsp;Alicia Rico ,&nbsp;Guillermo Ruíz-Carrascoso ,&nbsp;Maria Elena Palacios ,&nbsp;Eduardo Martín-Arranz ,&nbsp;Raquel Escudero-Nieto ,&nbsp;José I Bernardino","doi":"10.1016/j.eimce.2023.05.003","DOIUrl":"10.1016/j.eimce.2023.05.003","url":null,"abstract":"<div><h3>Introduction</h3><p><span>Human intestinal spirochetosis (HIE) is a poorly studied clinical entity with variable clinical manifestations. However, in recent years it has gained special relevance because an increasing number of cases have been described in people living with HIV (PWH) and </span>in patients<span> with a history of sexually transmitted infections (STI) or immunosuppression.</span></p></div><div><h3>Methods</h3><p>Retrospective review of all HIE cases identified in a tertiary level hospital (Hospital Universitario la Paz, Madrid) between 2014 and 2021.</p></div><div><h3>Results</h3><p><span><span>36 Cases of HIE were identified. Most cases corresponded to males (94%) with a median age of 45 years. 10 patients (29.4%) were PWH and 20 (56%) were men who had sex with men. Although the clinical manifestations were very heterogeneous, the most frequent was chronic diarrhea (47%), and up to 25% of the subjects had clinical </span>proctitis. 39% percent of patients had been diagnosed with an STI in the previous two years, this characteristic being more frequent in PWH (90% vs. 28%; p &lt; 0.01) than in patients without </span>HIV infection<span>. The STI most frequently associated with a diagnosis of HIE was syphilis (31%).</span></p></div><div><h3>Conclusion</h3><p>HIE is frequently diagnosed with other STIs and affects mostly men who have sex with men, which supports that this entity could be considered as a new STI.</p></div>","PeriodicalId":72916,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica (English ed.)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9540281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Elimination of hepatitis C virus in a prison: An 18-year experience 消除监狱中的丙型肝炎病毒:18 年的经验
Pub Date : 2024-05-01 DOI: 10.1016/j.eimce.2023.04.015
Maite Nogales-Garcia , Naiara Parraza Diez , Andoni Vargas Axpe , Rafael Velasco Garcia , Ane Larrabeiti-Etxebarria , Ignacio Roy Lopez-Cano , Inmaculada Atrio Alvarez , Asier Lopez de Arcaute Trincado , Eva María Fernandez Lopez de Vicuña , Ester Saez de Adana Arroniz , Carlos Martínez Martínez , Joseba Portu Zapirain

Introduction

Despite the decrease of hepatitis C in Spanish prisons in the last years, it still remains a reservoir for infection. The aim of this work is to analyze the characteristics of these patients and the response to antiviral treatment over the last 18 years.

Methods

Retrospective observational study in inmates of Araba penitentiary center diagnosed with HCV infection between 2002 and 2020.

A descriptive analysis of patient characteristics and the response to the three antiviral treatment modalities was performed: peg-interferon and ribavirin, peg-interferon, ribavirin and a first-generation protease inhibitor and different combinations of direct-acting antivirals.

Results

A total of 248 antiviral treatments were prescribed. Treatment response rate up to 2015 was 65% and 93,7% after that year. Interferon non-responders were the main cause of non-response to treatment in periods 1 and 2 (40%–50%). Conversely, in period 3 viral breakthrough (67%) was the main culprit.

Conclusion

After 18 years, active hepatitis C infection in prison inmates has resolved with treatment according to clinical criteria. Therefore, the stay in prison may represent an opportunity to reduce the reservoir of the disease in the community, together with continued health care for those released from prison.

导言尽管近年来西班牙监狱中丙型肝炎的发病率有所下降,但它仍然是一个传染源。本研究旨在分析这些患者的特征以及过去 18 年中对抗病毒治疗的反应。方法对 2002 年至 2020 年期间在阿拉巴监狱中心确诊感染 HCV 的囚犯进行回顾性观察研究。对患者特征和三种抗病毒治疗方式的反应进行了描述性分析:聚干扰素和利巴韦林,聚干扰素、利巴韦林和第一代蛋白酶抑制剂,以及直接作用抗病毒药物的不同组合。2015年之前的治疗应答率为65%,2015年之后为93.7%。干扰素无效者是第一和第二阶段治疗无效的主要原因(40%-50%)。结论18 年后,根据临床标准,监狱囚犯中的活动性丙型肝炎感染经治疗后已得到缓解。因此,在狱中服刑可能是减少社区中丙型肝炎病毒库的一个机会,同时也是为刑满释放人员提供持续医疗保健的一个机会。
{"title":"Elimination of hepatitis C virus in a prison: An 18-year experience","authors":"Maite Nogales-Garcia ,&nbsp;Naiara Parraza Diez ,&nbsp;Andoni Vargas Axpe ,&nbsp;Rafael Velasco Garcia ,&nbsp;Ane Larrabeiti-Etxebarria ,&nbsp;Ignacio Roy Lopez-Cano ,&nbsp;Inmaculada Atrio Alvarez ,&nbsp;Asier Lopez de Arcaute Trincado ,&nbsp;Eva María Fernandez Lopez de Vicuña ,&nbsp;Ester Saez de Adana Arroniz ,&nbsp;Carlos Martínez Martínez ,&nbsp;Joseba Portu Zapirain","doi":"10.1016/j.eimce.2023.04.015","DOIUrl":"10.1016/j.eimce.2023.04.015","url":null,"abstract":"<div><h3>Introduction</h3><p>Despite the decrease of hepatitis C in Spanish prisons in the last years, it still remains a reservoir for infection. The aim of this work is to analyze the characteristics of these patients and the response to antiviral treatment over the last 18 years.</p></div><div><h3>Methods</h3><p>Retrospective observational study in inmates of Araba penitentiary center diagnosed with HCV infection between 2002 and 2020.</p><p><span>A descriptive analysis of patient characteristics<span> and the response to the three antiviral treatment modalities was performed: peg-interferon and </span></span>ribavirin<span>, peg-interferon, ribavirin<span> and a first-generation protease inhibitor and different combinations of direct-acting antivirals.</span></span></p></div><div><h3>Results</h3><p><span>A total of 248 antiviral treatments were prescribed. Treatment response rate up to 2015 was 65% and 93,7% after that year. Interferon non-responders were the main cause of non-response to treatment in periods 1 and 2 (40%–50%). Conversely, in period 3 </span><em>viral breakthroug</em>h (67%) was the main culprit.</p></div><div><h3>Conclusion</h3><p>After 18 years, active hepatitis C infection in prison inmates has resolved with treatment according to clinical criteria. Therefore, the stay in prison may represent an opportunity to reduce the reservoir of the disease in the community, together with continued health care for those released from prison.</p></div>","PeriodicalId":72916,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica (English ed.)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9417493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrospective study of acute mastoiditis in children in Spain attended in a Pediatric Emergency department 西班牙儿科急诊室就诊儿童急性乳突炎的回顾性研究
Pub Date : 2024-05-01 DOI: 10.1016/j.eimce.2024.02.010
Paula García-Sánchez , Belén Parra Rodríguez , Rosario López López , Miguel Ángel Molina Gutiérrez , Marta Bueno Barriocanal , María de Ceano-Vivas la Calle

Objective

To analyze the cases of acute mastoiditis, characteristics, management and complications in children attended in the emergency department.

Methods

Retrospective study of acute mastoiditis in a Spanish tertiary hospital over a 6-year period (2018–2023).

Results

One hundred two episodes of acute mastoiditis were analyzed (54% males, median age 1.8 years). Microorganisms were isolated in one third of cases, mainly Streptococcus pyogenes (64% of ear secretion cultures). Complications occurred in 27.5%, primarily subperiosteal abscess. A younger age, absence of vaccination schedule, previous history of otitis, cochlear implant carriers or white blood cell counts and C-reactive protein levels were not associated with complications. Complicated cases had longer hospitalizations. Treatment included antibiotics, corticosteroids, and surgery in 50% of cases.

Conclusions

This study shows an increase of acute mastoiditis during 2023, with a relevant role of S. pyogenes. A younger age, absence of vaccination, personal history of otitis or cochlear implant, blood cell counts and C-reactive protein levels were not associated with complications.

目的 分析急诊科就诊儿童的急性乳突炎病例、特征、处理方法和并发症。方法 对西班牙一家三级医院 6 年内(2018-2023 年)的急性乳突炎病例进行回顾性研究。三分之一的病例分离出微生物,主要是化脓性链球菌(占耳分泌物培养的64%)。27.5%的病例出现并发症,主要是骨膜下脓肿。年龄较小、未接种疫苗、既往有中耳炎病史、人工耳蜗携带者或白细胞计数和C反应蛋白水平与并发症无关。并发症病例的住院时间较长。治疗包括抗生素、皮质类固醇,50%的病例接受了手术治疗。年龄较小、未接种疫苗、个人中耳炎或人工耳蜗植入史、血细胞计数和 C 反应蛋白水平与并发症无关。
{"title":"Retrospective study of acute mastoiditis in children in Spain attended in a Pediatric Emergency department","authors":"Paula García-Sánchez ,&nbsp;Belén Parra Rodríguez ,&nbsp;Rosario López López ,&nbsp;Miguel Ángel Molina Gutiérrez ,&nbsp;Marta Bueno Barriocanal ,&nbsp;María de Ceano-Vivas la Calle","doi":"10.1016/j.eimce.2024.02.010","DOIUrl":"https://doi.org/10.1016/j.eimce.2024.02.010","url":null,"abstract":"<div><h3>Objective</h3><p>To analyze the cases of acute mastoiditis, characteristics, management and complications in children attended in the emergency department.</p></div><div><h3>Methods</h3><p>Retrospective study of acute mastoiditis in a Spanish tertiary hospital over a 6-year period (2018–2023).</p></div><div><h3>Results</h3><p>One hundred two episodes of acute mastoiditis were analyzed (54% males, median age 1.8 years). Microorganisms were isolated in one third of cases, mainly <em>Streptococcus pyogenes</em> (64% of ear secretion cultures). Complications occurred in 27.5%, primarily subperiosteal abscess. A younger age, absence of vaccination schedule, previous history of otitis, cochlear implant carriers or white blood cell counts and C-reactive protein levels were not associated with complications. Complicated cases had longer hospitalizations. Treatment included antibiotics, corticosteroids, and surgery in 50% of cases.</p></div><div><h3>Conclusions</h3><p>This study shows an increase of acute mastoiditis during 2023, with a relevant role of <em>S. pyogenes</em>. A younger age, absence of vaccination, personal history of otitis or cochlear implant, blood cell counts and C-reactive protein levels were not associated with complications.</p></div>","PeriodicalId":72916,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica (English ed.)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140825134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular epidemiology of pneumococcal carriage in children from Seville, following implementation of the PCV13 immunization program in Andalusia, Spain 西班牙安达卢西亚实施 PCV13 免疫计划后塞维利亚儿童肺炎球菌携带的分子流行病学研究
Pub Date : 2024-04-01 DOI: 10.1016/j.eimce.2023.04.008
Beatriz de Felipe , Marta Aboza-García , Verónica González-Galán , Ignacio Salamanca de la Cueva , Juan Alfonso Martín-Quintero , Benito Amil-Pérez , Cristóbal Coronel-Rodríguez , María Ángeles Palacios-Soria , María Isabel García Ruiz-Santaquiteria , María José Torres-Sánchez , Francisco Javier Morón , Juan A. Cordero-Varela , Pablo Obando-Pacheco , Ignacio Obando

Introduction

The 13-valent pneumococcal conjugate vaccine (PCV13) universal vaccination programme was introduced in December 2016 in Andalusia.

Methods

A cross-sectional study was conducted on the molecular epidemiology of pneumococcal nasopharyngeal colonization. A total of 397 healthy children were recruited from primary healthcare centres in Seville for the periods 1/4/2018 to 28/2/2020 and 1/11/2021 to 28/2/2022 (PCV13 period). Data from a previous carriage study conducted among healthy and sick children from 1/01/2006 to 30/06/2008 (PCV7 period), were used for comparison of serotype/genotype distributions and antibiotic resistance rates.

Results

Overall, 76 (19%) children were colonized with S. pneumoniae during the PCV13 period and there were information available from 154 isolates collected during the PCV7 period. Colonization with PCV13 serotypes declined significantly in the PCV13 period compared with historical controls (11% vs 38%, p = 0.0001), being serotypes 19F (8%), 3 (1%) and 6B (1%) the only circulating vaccine types. Serotypes 15B/C and 11A were the most frequently identified non-PCV13 serotypes during the PCV13 period (14% and 11%, respectively); the later one increased significantly between time periods (p = 0.04). Serotype 11A was exclusively associated in the PCV13 period with ampicillin-resistant variants of the Spain9V-ST156 clone (ST6521 and genetically related ST14698), not detected in the preceding period.

Conclusions

There was a residual circulation of vaccine types following PCV13 introduction, apart from serotype 19F. Serotype 11A increased between PCV13 and PCV7 periods due to emergence and clonal expansion of ampicillin-resistant genotype ST6521.

方法 对肺炎球菌鼻咽部定植的分子流行病学进行了横断面研究。在 2018 年 1 月 4 日至 2020 年 2 月 28 日和 2021 年 11 月 1 日至 2022 年 2 月 28 日(PCV13 期间),塞维利亚初级医疗保健中心共招募了 397 名健康儿童。之前在 2006 年 1 月 1 日至 2008 年 6 月 30 日(PCV7 期间)对健康儿童和患病儿童进行的携带研究数据被用于比较血清型/基因型分布和抗生素耐药率。与历史对照组相比(11% vs 38%,p = 0.0001),PCV13 期间肺炎链球菌血清型的定植率显著下降,血清型 19F(8%)、3(1%)和 6B(1%)是唯一流行的疫苗类型。血清型 15B/C 和 11A 是 PCV13 期间最常发现的非 PCV13 血清型(分别为 14% 和 11%);后一种血清型在不同时期显著增加(p = 0.04)。在 PCV13 期间,血清型 11A 只与西班牙 9V-ST156 克隆的氨苄青霉素耐药变异株(ST6521 和基因相关的 ST14698)有关,而在前一时期未检测到这种变异株。由于耐氨苄西林基因型 ST6521 的出现和克隆扩增,血清型 11A 在 PCV13 和 PCV7 期间有所增加。
{"title":"Molecular epidemiology of pneumococcal carriage in children from Seville, following implementation of the PCV13 immunization program in Andalusia, Spain","authors":"Beatriz de Felipe ,&nbsp;Marta Aboza-García ,&nbsp;Verónica González-Galán ,&nbsp;Ignacio Salamanca de la Cueva ,&nbsp;Juan Alfonso Martín-Quintero ,&nbsp;Benito Amil-Pérez ,&nbsp;Cristóbal Coronel-Rodríguez ,&nbsp;María Ángeles Palacios-Soria ,&nbsp;María Isabel García Ruiz-Santaquiteria ,&nbsp;María José Torres-Sánchez ,&nbsp;Francisco Javier Morón ,&nbsp;Juan A. Cordero-Varela ,&nbsp;Pablo Obando-Pacheco ,&nbsp;Ignacio Obando","doi":"10.1016/j.eimce.2023.04.008","DOIUrl":"10.1016/j.eimce.2023.04.008","url":null,"abstract":"<div><h3>Introduction</h3><p>The 13-valent pneumococcal conjugate vaccine (PCV13) universal vaccination programme was introduced in December 2016 in Andalusia.</p></div><div><h3>Methods</h3><p><span><span>A cross-sectional study was conducted on the molecular epidemiology of pneumococcal nasopharyngeal colonization. A total of 397 healthy children were recruited from </span>primary healthcare centres in Seville for the periods 1/4/2018 to 28/2/2020 and 1/11/2021 to 28/2/2022 (PCV13 period). Data from a previous carriage study conducted among healthy and sick children from 1/01/2006 to 30/06/2008 (PCV7 period), were used for comparison of serotype/genotype distributions and </span>antibiotic resistance rates.</p></div><div><h3>Results</h3><p>Overall, 76 (19%) children were colonized with <span><span>S. pneumoniae</span></span> during the PCV13 period and there were information available from 154 isolates collected during the PCV7 period. Colonization with PCV13 serotypes declined significantly in the PCV13 period compared with historical controls (11% vs 38%, <em>p</em> = 0.0001), being serotypes 19F (8%), 3 (1%) and 6B (1%) the only circulating vaccine types. Serotypes 15B/C and 11A were the most frequently identified non-PCV13 serotypes during the PCV13 period (14% and 11%, respectively); the later one increased significantly between time periods (<em>p</em> = 0.04). Serotype 11A was exclusively associated in the PCV13 period with ampicillin-resistant variants of the Spain<sup>9V</sup>-ST156 clone (ST6521 and genetically related ST14698), not detected in the preceding period.</p></div><div><h3>Conclusions</h3><p>There was a residual circulation of vaccine types following PCV13 introduction, apart from serotype 19F. Serotype 11A increased between PCV13 and PCV7 periods due to emergence and clonal expansion of ampicillin-resistant genotype ST6521.</p></div>","PeriodicalId":72916,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica (English ed.)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9422464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Another bacterial etiology of brain granulomas 脑肉芽肿的另一种细菌病因。
Pub Date : 2024-04-01 DOI: 10.1016/j.eimce.2023.10.004
José Rincón , Angela Guarnizo , Carlos Rugilo
{"title":"Another bacterial etiology of brain granulomas","authors":"José Rincón ,&nbsp;Angela Guarnizo ,&nbsp;Carlos Rugilo","doi":"10.1016/j.eimce.2023.10.004","DOIUrl":"10.1016/j.eimce.2023.10.004","url":null,"abstract":"","PeriodicalId":72916,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica (English ed.)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139433257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Auritidibacter ignavus in ear discharge of paediatric patients: Two cases reports and literature review 儿科患者耳道分泌物中的点火弧菌:两份病例报告和文献综述。
Pub Date : 2024-04-01 DOI: 10.1016/j.eimce.2024.01.009
Pablo González-Moreno , Martina Araujo-Sánchez , Jonathan Fernández-Suárez , Javier Fernández-Dominguez , Jose Luis Llorente , María Soledad Zapico-González

Introduction

The development and research of new technologies for identifying microorganisms, has allowed the identification of hitherto unknown bacteria. Auritidibacter ignavus is a newly described Gram-positive rod possibly associated with otitis, although its role as an etiologic agent in otitis is currently controversial.

Methods

We report two cases of recurrent otitis in paediatric patients in which A. ignavus was isolated and review the previous cases reported in the literature.

Results

All the isolates were identified as A. ignavus by proteomic and genomic methods. Both patients recovered from their symptoms.

Conclusion

A. ignavus was recovered from ear discharges of paedriatic patients with chronic ear problems. All the cases previously reported in the literature were adults. More evidence is needed for the association between A. ignavus and otitis, since data regarding this species are still scarce.

导言:鉴定微生物的新技术的开发和研究使得迄今为止未知细菌的鉴定成为可能。点火弧菌是一种新发现的革兰氏阳性杆菌,可能与中耳炎有关,但它作为中耳炎病原体的作用目前还存在争议:方法:我们报告了两例小儿复发性中耳炎病例,其中分离出了点火杆菌,并回顾了以往文献报道的病例:结果:通过蛋白质组和基因组方法,所有分离物均被鉴定为点火甲虫。两名患者的症状均已痊愈:结论:从患有慢性耳部疾病的儿童患者的耳分泌物中发现了点火蚁。结论:从患有慢性耳病的儿童患者的耳道分泌物中发现了点火蚁。由于有关该物种的数据仍然很少,因此需要更多证据来证明点火甲虫与耳炎之间的联系。
{"title":"Auritidibacter ignavus in ear discharge of paediatric patients: Two cases reports and literature review","authors":"Pablo González-Moreno ,&nbsp;Martina Araujo-Sánchez ,&nbsp;Jonathan Fernández-Suárez ,&nbsp;Javier Fernández-Dominguez ,&nbsp;Jose Luis Llorente ,&nbsp;María Soledad Zapico-González","doi":"10.1016/j.eimce.2024.01.009","DOIUrl":"10.1016/j.eimce.2024.01.009","url":null,"abstract":"<div><h3>Introduction</h3><p>The development and research of new technologies for identifying microorganisms, has allowed the identification of hitherto unknown bacteria. <em>Auritidibacter ignavus</em><span> is a newly described Gram-positive rod possibly associated with otitis, although its role as an etiologic agent in otitis is currently controversial.</span></p></div><div><h3>Methods</h3><p>We report two cases of recurrent otitis in paediatric patients in which <em>A. ignavus</em> was isolated and review the previous cases reported in the literature.</p></div><div><h3>Results</h3><p>All the isolates were identified as <em>A. ignavus</em><span><span> by proteomic and genomic methods. Both patients recovered from their </span>symptoms.</span></p></div><div><h3>Conclusion</h3><p><em>A. ignavus</em> was recovered from ear discharges of paedriatic patients with chronic ear problems. All the cases previously reported in the literature were adults. More evidence is needed for the association between <em>A. ignavus</em> and otitis, since data regarding this species are still scarce.</p></div>","PeriodicalId":72916,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica (English ed.)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139543749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative severity of COVID-19 cases caused by Alpha, Delta or Omicron SARS-CoV-2 variants and its association with vaccination 由阿尔法、德尔塔或奥米克隆 SARS-CoV-2 变体引起的 COVID-19 病例的严重程度比较及其与疫苗接种的关系。
Pub Date : 2024-04-01 DOI: 10.1016/j.eimce.2022.11.021
Elena Varea-Jiménez , Esteban Aznar Cano , Lorena Vega-Piris , Elena Vanessa Martínez Sánchez , Clara Mazagatos , Lucía García San Miguel Rodríguez-Alarcón , Inmaculada Casas , María José Sierra Moros , Maria Iglesias-Caballero , Sonia Vazquez-Morón , Amparo Larrauri , Susana Monge , Working group for the surveillance and control of COVID-19

Background

This study compares the severity of SARS-CoV-2 infections caused by Alpha, Delta or Omicron variants in periods of co-circulation in Spain, and estimates the variant-specific association of vaccination with severe disease.

Methods

SARS-CoV-2 infections notified to the national epidemiological surveillance network with information on genetic variant and vaccination status were considered cases if they required hospitalisation or controls otherwise. Alpha and Delta were compared during June–July 2021; and Delta and Omicron during December 2021–January 2022. Adjusted odds ratios (aOR) were estimated using logistic regression, comparing variant and vaccination status between cases and controls.

Results

We included 5,345 Alpha and 11,974 Delta infections in June–July and 5,272 Delta and 10,578 Omicron in December–January. Unvaccinated cases of Alpha (aOR: 0.57; 95% CI: 0.46–0.69) or Omicron (0.28; 0.21–0.36) had lower probability of hospitalisation vs. Delta. Complete vaccination reduced hospitalisation, similarly for Alpha (0.16; 0.13–0.21) and Delta (June–July: 0.16; 0.14–0.19; December–January: 0.36; 0.30–0.44) but lower from Omicron (0.63; 0.53–0.75) and individuals aged 65+ years.

Conclusion

Results indicate higher intrinsic severity of the Delta variant, compared with Alpha or Omicron, with smaller differences among vaccinated individuals. Nevertheless, vaccination was associated to reduced hospitalisation in all groups.

背景:本研究比较了西班牙共同流行期间由 Alpha、Delta 或 Omicron 变种引起的 SARS-CoV-2 感染的严重程度,并估算了接种疫苗与严重疾病之间的特定变异关系:向国家流行病学监测网络通报的 SARS-CoV-2 感染病例,如果需要住院治疗,则被视为病例;如果不需要住院治疗,则被视为对照组。在 2021 年 6 月至 7 月期间,对 Alpha 和 Delta 进行比较;在 2021 年 12 月至 2022 年 1 月期间,对 Delta 和 Omicron 进行比较。使用逻辑回归法估算调整后的几率比(aOR),比较病例和对照组之间的变异和疫苗接种情况:我们纳入了 6 月至 7 月的 5,345 例阿尔法型和 11,974 例德尔塔型感染病例,以及 12 月至 1 月的 5,272 例德尔塔型和 10,578 例奥米克龙型感染病例。未接种疫苗的阿尔法病例(aOR:0.57;95% CI:0.46-0.69)或奥米克隆病例(0.28;0.21-0.36)与德尔塔病例相比,住院概率较低。完全接种疫苗可降低住院率,阿尔法(0.16;0.13-0.21)和德尔塔(6-7 月:0.16;0.14-0.19;12-1 月:0.36;0.30-0.44)的情况类似,但奥米克龙(0.63;0.53-0.75)和 65 岁以上人群的住院率较低:结果表明,与阿尔法或奥米克龙变体相比,德尔塔变体的内在严重性更高,但接种疫苗者之间的差异较小。尽管如此,接种疫苗还是减少了所有群体的住院率。
{"title":"Comparative severity of COVID-19 cases caused by Alpha, Delta or Omicron SARS-CoV-2 variants and its association with vaccination","authors":"Elena Varea-Jiménez ,&nbsp;Esteban Aznar Cano ,&nbsp;Lorena Vega-Piris ,&nbsp;Elena Vanessa Martínez Sánchez ,&nbsp;Clara Mazagatos ,&nbsp;Lucía García San Miguel Rodríguez-Alarcón ,&nbsp;Inmaculada Casas ,&nbsp;María José Sierra Moros ,&nbsp;Maria Iglesias-Caballero ,&nbsp;Sonia Vazquez-Morón ,&nbsp;Amparo Larrauri ,&nbsp;Susana Monge ,&nbsp;Working group for the surveillance and control of COVID-19","doi":"10.1016/j.eimce.2022.11.021","DOIUrl":"10.1016/j.eimce.2022.11.021","url":null,"abstract":"<div><h3>Background</h3><p>This study compares the severity of SARS-CoV-2 infections caused by Alpha, Delta or Omicron variants in periods of co-circulation in Spain, and estimates the variant-specific association of vaccination with severe disease.</p></div><div><h3>Methods</h3><p>SARS-CoV-2 infections notified to the national epidemiological surveillance network with information on genetic variant and vaccination status were considered cases if they required hospitalisation or controls otherwise. Alpha and Delta were compared during June–July 2021; and Delta and Omicron during December 2021–January 2022. Adjusted odds ratios (aOR) were estimated using logistic regression, comparing variant and vaccination status between cases and controls.</p></div><div><h3>Results</h3><p>We included 5,345 Alpha and 11,974 Delta infections in June–July and 5,272 Delta and 10,578 Omicron in December–January. Unvaccinated cases of Alpha (aOR: 0.57; 95% CI: 0.46–0.69) or Omicron (0.28; 0.21–0.36) had lower probability of hospitalisation vs. Delta. Complete vaccination reduced hospitalisation, similarly for Alpha (0.16; 0.13–0.21) and Delta (June–July: 0.16; 0.14–0.19; December–January: 0.36; 0.30–0.44) but lower from Omicron (0.63; 0.53–0.75) and individuals aged 65+ years.</p></div><div><h3>Conclusion</h3><p>Results indicate higher intrinsic severity of the Delta variant, compared with Alpha or Omicron, with smaller differences among vaccinated individuals. Nevertheless, vaccination was associated to reduced hospitalisation in all groups.</p></div>","PeriodicalId":72916,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica (English ed.)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890374/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9220574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rapid antibiotic susceptibility testing (RAST) of blood cultures in enterobacteria with inducible chromosomal AmpC-type β-lactamase 对带有诱导性染色体 AmpC 型 β-内酰胺酶的肠杆菌血液培养物进行快速抗生素敏感性测试 (RAST)
Pub Date : 2024-04-01 DOI: 10.1016/j.eimce.2023.12.002
Blanca Carrasco, Gloria Zaragoza, David M. Arana, Yolanda Hernández-Hermida, Juan-Ignacio Alós

Introduction

Early and adequate treatment of bloodstream infections decreases patient morbidity and mortality. The objective is to develop a preliminary method for rapid antibiotic susceptibility testing (RAST) in enterobacteria with inducible chromosomal AmpC.

Methods

RAST was performed directly on spiked blood cultures of 49 enterobacteria with inducible chromosomal AmpC. Results were read at 4, 6 and 8 h of incubation. Commercial broth microdilution was considered the reference method. Disks of 10 antibiotics were evaluated.

Results

The proportion of readable tests at 4 h was 85%. All RAST could be read at 6 and 8 h.

For most antibiotics, the S or R result at 4, 6 and 8 h was greater than 80% after tentative breakpoints were established and Area of Technical Uncertainty was defined.

Conclusions

This preliminary method seems to be of practical use, although it should be extended to adjust the breakpoints and differentiate them by species.

引言及早、充分治疗血流感染可降低患者的发病率和死亡率。方法直接对 49 种具有诱导性染色体 AmpC 的肠道细菌的血液培养物进行快速抗生素敏感性检测(RAST)。结果在培养 4、6 和 8 小时后读取。商用肉汤微量稀释法被视为参考方法。结果 4 小时可读取结果的比例为 85%。对于大多数抗生素来说,在确定了暂定断点和技术不确定区域后,4、6 和 8 小时的 S 或 R 结果均大于 80%。结论这种初步方法似乎很实用,但应加以扩展,以调整断点并按物种加以区分。
{"title":"Rapid antibiotic susceptibility testing (RAST) of blood cultures in enterobacteria with inducible chromosomal AmpC-type β-lactamase","authors":"Blanca Carrasco,&nbsp;Gloria Zaragoza,&nbsp;David M. Arana,&nbsp;Yolanda Hernández-Hermida,&nbsp;Juan-Ignacio Alós","doi":"10.1016/j.eimce.2023.12.002","DOIUrl":"https://doi.org/10.1016/j.eimce.2023.12.002","url":null,"abstract":"<div><h3>Introduction</h3><p>Early and adequate treatment of bloodstream infections decreases patient morbidity and mortality. The objective is to develop a preliminary method for rapid antibiotic susceptibility testing (RAST) in enterobacteria with inducible chromosomal AmpC.</p></div><div><h3>Methods</h3><p>RAST was performed directly on spiked blood cultures of 49 enterobacteria with inducible chromosomal AmpC. Results were read at 4, 6 and 8<!--> <!-->h of incubation. Commercial broth microdilution was considered the reference method. Disks of 10 antibiotics were evaluated.</p></div><div><h3>Results</h3><p>The proportion of readable tests at 4<!--> <!-->h was 85%. All RAST could be read at 6 and 8<!--> <!-->h.</p><p>For most antibiotics, the S or R result at 4, 6 and 8<!--> <!-->h was greater than 80% after tentative breakpoints were established and Area of Technical Uncertainty was defined.</p></div><div><h3>Conclusions</h3><p>This preliminary method seems to be of practical use, although it should be extended to adjust the breakpoints and differentiate them by species.</p></div>","PeriodicalId":72916,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica (English ed.)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140339402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Executive summary: Guidelines for the diagnosis and treatment of septic arthritis in adults and children, developed by the GEIO (SEIMC), SEIP and SECOT 执行摘要:GEIO(SEIMC)、SEIP和SECOT制定的成人和儿童感染性关节炎诊断和治疗指南。
Pub Date : 2024-04-01 DOI: 10.1016/j.eimce.2023.07.007
Natividad Benito , Juan Carlos Martínez-Pastor , Jaime Lora-Tamayo , Javier Ariza , José Baeza , Joaquín Belzunegui-Otano , Javier Cobo , María-Dolores del-Toro , Cesar G. Fontecha , Lluís Font-Vizcarra , Juan P. Horcajada , Laura Morata , Oscar Murillo , Joan M. Nolla , Esmeralda Núñez-Cuadros , Carlos Pigrau , María Eugenia Portillo , Dolors Rodríguez-Pardo , Beatriz Sobrino-Díaz , Jesús Saavedra-Lozano

Infection of a native joint, commonly referred to as septic arthritis, is a medical emergency because of the risk of joint destruction and subsequent sequelae. Its diagnosis requires a high level of suspicion. These guidelines for the diagnosis and treatment of septic arthritis in children and adults are intended for use by any physician caring for patients with suspected or confirmed septic arthritis. They have been developed by a multidisciplinary panel with representatives from the Bone and Joint Infections Study Group (GEIO) belonging to the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Paediatric Infections (SEIP) and the Spanish Society of Orthopaedic Surgery and Traumatology (SECOT), and two rheumatologists. The recommendations are based on evidence derived from a systematic literature review and, failing that, on the opinion of the experts who prepared these guidelines. A detailed description of the background, methods, summary of evidence, the rationale supporting each recommendation, and gaps in knowledge can be found online in the complete document.

原生关节感染,通常被称为感染性关节炎,是一种医疗紧急情况,因为有关节破坏和随后后遗症的风险。它的诊断需要高度怀疑。这些儿童和成人感染性关节炎的诊断和治疗指南旨在供任何护理疑似或确诊感染性关节病患者的医生使用。它们是由一个多学科小组开发的,该小组的代表来自西班牙传染病和临床微生物学学会(SEIMC)的骨和关节感染研究小组(GEIO)、西班牙儿科感染学会(SEIP)和西班牙整形外科和创伤学学会(SECOT),以及两名风湿病学家。这些建议基于系统文献综述中的证据,如果没有,则基于编写这些指南的专家的意见。关于背景、方法、证据摘要、支持每项建议的理由以及知识差距的详细描述,可以在完整的文件中在线找到。
{"title":"Executive summary: Guidelines for the diagnosis and treatment of septic arthritis in adults and children, developed by the GEIO (SEIMC), SEIP and SECOT","authors":"Natividad Benito ,&nbsp;Juan Carlos Martínez-Pastor ,&nbsp;Jaime Lora-Tamayo ,&nbsp;Javier Ariza ,&nbsp;José Baeza ,&nbsp;Joaquín Belzunegui-Otano ,&nbsp;Javier Cobo ,&nbsp;María-Dolores del-Toro ,&nbsp;Cesar G. Fontecha ,&nbsp;Lluís Font-Vizcarra ,&nbsp;Juan P. Horcajada ,&nbsp;Laura Morata ,&nbsp;Oscar Murillo ,&nbsp;Joan M. Nolla ,&nbsp;Esmeralda Núñez-Cuadros ,&nbsp;Carlos Pigrau ,&nbsp;María Eugenia Portillo ,&nbsp;Dolors Rodríguez-Pardo ,&nbsp;Beatriz Sobrino-Díaz ,&nbsp;Jesús Saavedra-Lozano","doi":"10.1016/j.eimce.2023.07.007","DOIUrl":"10.1016/j.eimce.2023.07.007","url":null,"abstract":"<div><p>Infection of a native joint, commonly referred to as septic arthritis, is a medical emergency because of the risk of joint destruction and subsequent sequelae. Its diagnosis requires a high level of suspicion. These guidelines for the diagnosis and treatment of septic arthritis in children and adults are intended for use by any physician caring for patients with suspected or confirmed septic arthritis. They have been developed by a multidisciplinary panel with representatives from the Bone and Joint Infections Study Group (GEIO) belonging to the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Paediatric Infections (SEIP) and the Spanish Society of Orthopaedic Surgery and Traumatology (SECOT), and two rheumatologists. The recommendations are based on evidence derived from a systematic literature review and, failing that, on the opinion of the experts who prepared these guidelines. A detailed description of the background, methods, summary of evidence, the rationale supporting each recommendation, and gaps in knowledge can be found online in the complete document.</p></div>","PeriodicalId":72916,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica (English ed.)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71429759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mycobacterium malmoense wrist septic arthritis 恶性分枝杆菌腕关节化脓性关节炎
Pub Date : 2024-04-01 DOI: 10.1016/j.eimce.2024.01.011
Raquel Fernández González , Ricardo Fernández Rodríguez , Pedro Luis Prieto Casal , Eva Salgado
{"title":"Mycobacterium malmoense wrist septic arthritis","authors":"Raquel Fernández González ,&nbsp;Ricardo Fernández Rodríguez ,&nbsp;Pedro Luis Prieto Casal ,&nbsp;Eva Salgado","doi":"10.1016/j.eimce.2024.01.011","DOIUrl":"10.1016/j.eimce.2024.01.011","url":null,"abstract":"","PeriodicalId":72916,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica (English ed.)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139543759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Enfermedades infecciosas y microbiologia clinica (English ed.)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1